John Hussman's PFE Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 42,000 shares of Pfizer Inc. (PFE) worth $1.05 M, representing 0.25% of the portfolio. First purchased in 2014-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in PFE, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 63,000 shares. Largest reduction occurred in Q2 2024, reducing 63,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2014 | +17,000 | New Buy | 17,000 | $32.12 |
| Q2 2014 | -17,000 | Sold Out | 0 | $0.00 |
| Q4 2021 | +57,200 | New Buy | 57,200 | $59.06 |
| Q1 2022 | +10,400 | Add 18.18% | 67,600 | $51.78 |
| Q2 2022 | +25,400 | Add 37.57% | 93,000 | $52.43 |
| Q3 2022 | +31,000 | Add 33.33% | 124,000 | $43.76 |
| Q2 2023 | -20,000 | Reduce 16.13% | 104,000 | $36.68 |
| Q4 2023 | +22,000 | Add 21.15% | 126,000 | $28.79 |
| Q1 2024 | -21,000 | Reduce 16.67% | 105,000 | $27.75 |
| Q2 2024 | -63,000 | Reduce 60.00% | 42,000 | $27.98 |
| Q3 2024 | -42,000 | Sold Out | 0 | $0.00 |
| Q1 2025 | +63,000 | New Buy | 63,000 | $25.34 |
| Q2 2025 | -63,000 | Sold Out | 0 | $0.00 |
| Q4 2025 | +42,000 | New Buy | 42,000 | $24.90 |
John Hussman's Pfizer Investment FAQs
John Hussman first purchased Pfizer Inc. (PFE) in Q1 2014, acquiring 17,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Pfizer Inc. (PFE) for 17 quarters since Q1 2014.
John Hussman's largest addition to Pfizer Inc. (PFE) was in Q1 2025, adding 63,000 shares worth $1.6 M.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 42,000 shares of Pfizer Inc. (PFE), valued at approximately $1.05 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.25% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Pfizer Inc. (PFE) was 126,000 shares, as reported at the end of Q4 2023.